Search Results - "Balcomb BH"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Fragment-Based Design of Targeted Covalent Inhibitors: The Scope and Limitation of Linking Approaches.

    Authors: Kollár L Mihalovits LM Bajusz D et al.

    Source: ChemMedChem [ChemMedChem] 2026 May 27; Vol. 21 (10), pp. e202501108.

    Publication Type: Journal Article

    Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101259013 Publication Model: Print Cited Medium: Internet ISSN: 1860-7187 (Electronic) Linking ISSN: 18607179 NLM ISO Abbreviation: ChemMedChem Subsets: MEDLINE

    Save to List
  2. 2

    Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors.

    Authors: Ni X Richardson RB Godoy AS et al.

    Source: Nature communications [Nat Commun] 2025 Oct 08; Vol. 16 (1), pp. 8930. Date of Electronic Publication: 2025 Oct 08.

    Publication Type: Journal Article

    Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  3. 3

    High-throughput crystallographic fragment screening of Zika virus NS3 Helicase.

    Authors: Godoy AS Giroud C Mesquita NCMR et al.

    Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Sep 23. Date of Electronic Publication: 2025 Sep 23.

    Publication Type: Journal Article; Preprint

    Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

    Save to List
  4. 4

    Crystallographic Fragment Screening of the Dengue Virus Polymerase Reveals Multiple Binding Sites for the Development of Non-nucleoside Antiflavivirals.

    Authors: Saini M Aschenbrenner JC Ruiz FX et al.

    Source: Journal of medicinal chemistry [J Med Chem] 2025 Sep 11; Vol. 68 (17), pp. 18356-18369. Date of Electronic Publication: 2025 Sep 02.

    Publication Type: Journal Article

    Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

    Save to List
  5. 5

    Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.

    Authors: Boby ML Fearon D Ferla M et al.

    Corporate Authors: Boby ML Fearon D Ferla M et al.

    Source: Science (New York, N.Y.) [Science] 2023 Nov 10; Vol. 382 (6671), pp. eabo7201. Date of Electronic Publication: 2023 Nov 10.

    Publication Type: Journal Article

    Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  6. 6

    A Structure-Based Computational Pipeline for Broad-Spectrum Antiviral Discovery.

    Authors: Castellanos MA Payne AM Scheen J et al.

    Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Jul 30. Date of Electronic Publication: 2025 Jul 30.

    Publication Type: Journal Article; Preprint

    Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

    Save to List
  7. 7

    Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor.

    Authors: Griffen EJ Fearon D McGovern BL et al.

    Corporate Authors: Griffen EJ Fearon D McGovern BL et al.

    Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Jun 17. Date of Electronic Publication: 2025 Jun 17.

    Publication Type: Journal Article; Preprint

    Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

    Save to List
  8. 8

    Crystallographic fragment screening of the dengue virus polymerase reveals multiple binding sites for the development of non-nucleoside antiflavivirals.

    Authors: Saini M Aschenbrenner JC Ruiz FX et al.

    Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Apr 05. Date of Electronic Publication: 2025 Apr 05.

    Publication Type: Journal Article; Preprint

    Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: In Process

    Save to List
  9. 9

    Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors.

    Authors: Ni X Richardson RB Godoy AS et al.

    Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Feb 13. Date of Electronic Publication: 2025 Feb 13.

    Publication Type: Journal Article; Preprint

    Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

    Save to List
  10. 10

    Identifying novel chemical matter against the Chikungunya virus nsP3 macrodomain through crystallographic fragment screening.

    Authors: Aschenbrenner JC de Godoy AS Fairhead M et al.

    Source: BioRxiv : the preprint server for biology [bioRxiv] 2024 Aug 23. Date of Electronic Publication: 2024 Aug 23.

    Publication Type: Journal Article; Preprint

    Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

    Save to List
  11. 11

    Crystallographic Fragment Screen of Coxsackievirus A16 2A Protease identifies new opportunities for the development of broad-spectrum anti-enterovirals.

    Authors: Lithgo RM Tomlinson CWE Fairhead M et al.

    Source: BioRxiv : the preprint server for biology [bioRxiv] 2024 Apr 29. Date of Electronic Publication: 2024 Apr 29.

    Publication Type: Preprint; Journal Article

    Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

    Save to List

Search Tools: